At the news
? NEUTRALIMPACT 3/10 8-K filed Apr 3, 2026 at 15:06 ET
Rhythm Pharmaceuticals announced the appointment of Kimberly Popovits to its Board of Directors and the resignation of Edward T. Mathers, effective April 1, 2026. The changes reflect a routine board transition, with Popovits bringing extensive biopharma leadership experience and Mathers departing amicably after years of service.
- Kimberly J. Popovits appointed to the Board of Directors effective April 1, 2026, as a Class II director
- Edward T. Mathers resigned from the Board effective April 1, 2026, with no disagreement with the company
- Popovits has prior leadership experience as CEO of Genomic Health and senior roles at Genentech
- No financial terms, compensation changes, or strategic shifts were disclosed in connection with the board changes
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access